Cargando…

Hexoprenaline Compared with Atosiban as Tocolytic Treatment for Preterm Labor

Introduction Preterm birth is defined as a live birth before 37 weeks of gestation and is associated with increased neonatal morbidity and mortality. The aim of this study is to compare the efficacy of hexoprenaline and atosiban for short- and long-term tocolysis and their effects on neonatal and ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirchhoff, Ebba, Schneider, Verena, Pichler, Gerhard, Reif, Philipp, Haas, Josef, Joksch, Maike, Mager, Corinna, Schmied, Christian, Schöll, Wolfgang, Pichler-Stachl, Elisabeth, Gold, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365465/ https://www.ncbi.nlm.nih.gov/pubmed/35967742 http://dx.doi.org/10.1055/a-1823-0176

Ejemplares similares

Management of preterm labor: atosiban or nifedipine?
por: de Heus, Roel, et al.
Publicado: (2010)

Critical appraisal and clinical utility of atosiban in the management of preterm labor
por: Sanu, Olaleye, et al.
Publicado: (2010)

Maternal serum cytokines in the prediction of preterm labor and response to tocolytic therapy in preterm labor women
por: Shahshahan, Zahra, et al.
Publicado: (2014)

The use of maternal C-reactive protein in the predicting of preterm labor and tocolytic therapy in preterm labor women
por: Shahshahan, Zahra, et al.
Publicado: (2014)

Randomized Trial of Antibiotics in Addition to Tocolytic Therapy to Treat Preterm Labor
por: Watts, D. Heather, et al.
Publicado: (1994)

Electrohysterogram for ANN-Based Prediction of Imminent Labor in Women with Threatened Preterm Labor Undergoing Tocolytic Therapy
por: Mas-Cabo, J., et al.
Publicado: (2020)

Short-term tocolytics for preterm delivery – current perspectives
por: Haas, David M, et al.
Publicado: (2014)

Maternal serum interleukin 6 and 8 and C-reactive protein in predicting the tocolytic therapy in preterm labor
por: Shahshahan, Zahra, et al.
Publicado: (2014)

Tocolytic therapy for preterm delivery: systematic review and network meta-analysis
por: Haas, David M, et al.
Publicado: (2012)

Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth
por: Grzesiak, Mariusz, et al.
Publicado: (2018)

Maternal plasma nitric oxide metabolites and cervical length assessment in predicting the tocolytic therapy in preterm labor in Isfahan
por: Shahshahan, Zahra, et al.
Publicado: (2016)

Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor
por: Chollet, André, et al.
Publicado: (2007)

Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
por: Kawagoe, Yasuyuki, et al.
Publicado: (2011)

Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
por: Wex, Jaro, et al.
Publicado: (2009)

Association of Intraventricular Hemorrhage and Death With Tocolytic Exposure in Preterm Infants
por: Pinto Cardoso, Gaëlle, et al.
Publicado: (2018)

Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
por: Arman, Bridget M., et al.
Publicado: (2023)

Antenatal Consultation and Postnatal Stress in Mothers of Preterm Neonates (A Two-Center Observational Case–Control Study)
por: Pichler-Stachl, Elisabeth, et al.
Publicado: (2017)

Parental Stress Experience and Age of Mothers and Fathers After Preterm Birth and Admission of Their Neonate to Neonatal Intensive Care Unit; A Prospective Observational Pilot Study
por: Pichler-Stachl, Elisabeth, et al.
Publicado: (2019)

Cerebral oxygenation immediately after birth and long-term outcome in preterm neonates—a retrospective analysis
por: Wolfsberger, Christina H., et al.
Publicado: (2023)

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study
por: de Heus, Roel, et al.
Publicado: (2009)

Flow Injection Potentiometric Assay of Hexoprenaline in Its Pure State, Pharmaceutical Preparations, and Biological Samples
por: El-Nashar, Rasha M.
Publicado: (2008)

The Effects of Progesterone Therapy on the Gestation Length and Reduction of Neonatal Complications in Patients who had Received Tocolytic Therapy for Acute Phase of Preterm Labor
por: Lotfalizadeh, Marzie, et al.
Publicado: (2013)

Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes
por: Vogel, Joshua P, et al.
Publicado: (2022)

Different impacts of various tocolytic agents on increased risk of postoperative hemorrhage in preterm labor women undergoing Cesarean delivery: A population-based cohort study
por: Lee, Hua-Lin, et al.
Publicado: (2020)

Success rate in preterm uterine contraction inhibition with tocolytic agents in a tertiary care center
por: Kiatsuda, Duangsamorn, et al.
Publicado: (2016)

Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review
por: Sebastian, Elizabeth, et al.
Publicado: (2022)

Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial
por: Fu, Shuai, et al.
Publicado: (2021)

Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
por: Klumper, Job, et al.
Publicado: (2019)

Non-Cardiogenic Pulmonary Edema Due to Administration of Atosiban
por: Dalkalitsis, Alexandros, et al.
Publicado: (2023)

Tocolytic Therapy Inhibiting Preterm Birth in High-Risk Populations: A Systematic Review and Meta-Analysis
por: Yamaji, Noyuri, et al.
Publicado: (2023)

Correction: Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
Publicado: (2022)

Pregnancy-Related Stress Among Pregnant Women Receiving Tocolytic and Non-Tocolytic Treatments Where Both Used Complementary Medicine
por: Hsu, Chen-Yuan, et al.
Publicado: (2022)

Development and Validation of a Stability-Indicating UPLC Method for the Determination of Hexoprenaline in Injectable Dosage Form Using AQbD Principles
por: Afonso Urich, Jesús Alberto, et al.
Publicado: (2021)

Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective: A Survey of Taiwanese Obstetric Specialists
por: Lee, Howard Hao, et al.
Publicado: (2022)

Corrigendum: Pregnancy-related stress among pregnant women receiving tocolytic and non-tocolytic treatments where both used complementary medicine
por: Hsu, Chen-Yuan, et al.
Publicado: (2022)

Development and validation of a self-reported questionnaire to assess occupational balance in parents of preterm infants
por: Dür, Mona, et al.
Publicado: (2021)

Effects of exogenous oxytocin and atosiban antagonist on GABA in different region of brain
por: Thakur, Pratibha, et al.
Publicado: (2019)

Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles
por: Li, Xiufang, et al.
Publicado: (2023)

Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience
por: Al-Riyami, Nihal, et al.
Publicado: (2021)

The Oxytocin-Oxytocin Receptor System and Its Antagonists as Tocolytic Agents
por: Vrachnis, Nikolaos, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_88doeficdah4g67dahv2ulavl4